Paul Tudor Jones Simulations Plus, Inc. Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$33.36 - $45.71 $1.07 Million - $1.46 Million	-31,947 Reduced 79.03%	8,477 $379,000
Q3 2023 Nov 15, 2023	BUY	$40.03 - $51.51 $1.14 Million - $1.47 Million	28,559 Added 240.7%	40,424 $1.69 Million
Q2 2023 Aug 14, 2023	SELL	$40.45 - $48.0 $5,298 - $6,288	-131 Reduced 1.09%	11,865 $514,000
Q1 2023 May 15, 2023	SELL	$34.96 - $43.94 $453,116 - $569,506	-12,961 Reduced 51.93%	11,996 $527,000
Q4 2022 Feb 14, 2023	SELL	$36.55 - $51.15 $732,059 - $1.02 Million	-20,029 Reduced 44.52%	24,957 $913,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $1.43 Million - $2 Million	29,957 Added 199.33%	44,986 $2.18 Million
Q2 2022 Aug 15, 2022	BUY	$40.55 - $51.76 $609,425 - $777,901	15,029 New	15,029 $741,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.